HLA-lacking clones in aplastic anaemia: Adaptive or maladaptive?
Carmelo Gurnari1,2, Alberto Cardoso Martins Lima3,4, Simona Pagliuca5,6
1Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
British Journal of Haematology
|August 26, 2024
Summary
Human leukocyte antigen (HLA)-deficient clones may overcome immune attacks in aplastic anemia. This immune evasion mechanism offers potential new strategies for rescuing bone marrow function.
Area of Science:
- Immunology
- Hematology
- Genetics
Background:
- Immune responses critically influence bone marrow clonal dynamics in severe aplastic anemia.
- Human leukocyte antigen (HLA) expression is a key factor in immune recognition and T-cell mediated destruction of hematopoietic cells.
Purpose of the Study:
- To investigate the role of HLA-deficient clones in hematopoietic regeneration in severe aplastic anemia.
- To explore potential therapeutic implications of HLA loss in managing aplastic anemia.
Main Methods:
- Analysis of clonal dynamics in a patient with severe aplastic anemia.
- Assessment of HLA expression on hematopoietic cells.
- Monitoring of hematopoietic recovery without standard immunosuppressive therapy.
Main Results:
- Identification of a human leukocyte antigen (HLA)-deficient clone contributing to hematopoiesis.
- Demonstration of hematopoietic regeneration driven by HLA-loss variants.
- The patient achieved hematologic recovery without immunosuppressive treatment.
Conclusions:
- HLA loss can be an adaptive mechanism for hematopoietic stem cells to escape immune attack in aplastic anemia.
- Targeting or leveraging HLA-deficient clones may represent a novel therapeutic avenue for severe aplastic anemia.
More Related Videos
Related Concept Videos
01:40Cell-mediated Immune Responses
67.9K
Overview
67.9K
01:23Cells of the Adaptive Immune Response
972
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
972
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:19Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
01:25Immunodeficiency Diseases
926
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
926
01:22Bone Marrow Sampling and Transplants
316
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
316